SCHEMBL6840109

SCHEMBL6840109

FC(F)(F)c1nc2ccccc2c2c1nc(-c1cccs1)n2CCC1CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.38
HPGD P15428 11/20 0.38
ALDH1A1 P00352 10/20 0.38
HSD17B10 Q99714 5/20 0.38
MAPT P10636 4/20 0.38
TSHR P16473 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.36
ACP1 P24666 1/20 0.36
GLA P06280 4/20 0.36
GAA P10253 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
NPY1R P25929 1/20 0.35
HTT P42858 1/20 0.35
RCE1 Q9Y256 1/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840088 0.90 MAPT (0.35) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6838733 0.90 CCR3 (0.33) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6838050 0.89 HTR6 (0.38) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6929021 0.88 KDM4E (0.40) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6840138 0.88 NPY1R (0.35) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6833989 0.87 HTR4 (0.37) KDM4EACP1NPY1RPOLBCYP1A2
SCHEMBL6927683 0.87 NPY1R (0.40) KDM4EHPGDALDH1A1HSD17B10MAPT
SCHEMBL6833713 0.87 NPY1R (0.39) ACP1NPY1RCYP1A2CYP2C19HTR4
SCHEMBL6838657 0.86 NPY1R (0.36) ACP1NPY1RCYP1A2CYP2C19HTR4
SCHEMBL6833988 0.86 HTR4 (0.36) KDM4EALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 KDM4E 2253/4885HPGD 394/4885ALDH1A1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.